Fierce Biotech Summit 2024

As the biotech industry continues to deliver cutting-edge innovations, pharma companies like Novartis are partnering to share expertise, scale these discoveries and accelerate their path to market, all in service of the patient. In light of ever-increasing competition and costs, more collaboration and partnerships are needed in order to bring these new medicines to the patients who need them. Pharma companies and biotech need to join forces to ensure that the most promising innovations have the best chance of reaching patients. Hear how Novartis has adopted a ‘deal type agnostic’ approach which has led to successful collaborations and partnerships that maximize mutual value and focus on improving patient care.

Interviewed by: Michelle Benz, Fierce